In 2022, Brazil's export of leaf products (its main sales item) reached a high of 2.2 billion US dollars, the best since 2014, when sales on the international market amounted to 2.3 billion US dollars. The total shipment volume for the entire year of 2022 also set a new historical record at 412,000 tons. When including other tobacco products traded by Brazilian companies, the annual total value reached 2.45 billion US dollars.
The total annual sales for cigars and cigarettes were $156.33 million, with a volume of 3.21 thousand tons. Negotiation amounts for stems and extracts reached $59.25 million, with sales of 13.69 thousand tons. Raw tobacco had a total annual sales of $34.5 million, with a shipment volume of 3,400 tons.
Compared to the results in 2021, the sales revenue of tobacco exports has increased by 72%. In terms of export volume, this proportion has reached 30.7%. Throughout 2021, the total trading volume of tobacco was $1.2 billion with a shipment of 31.54 million tonnes. It is worth noting that the export in 2021 was affected by the pandemic and logistic restrictions.
The European market serves as the primary destination for Brazilian tobacco, with Belgium accounting for 28% of shipments and generating a revenue of $610 million. Belgium is seen as a gateway to the European Union. China ranks second, accounting for 21% of business and $471 million in sales. The United States is the third largest destination for Brazilian tobacco, comprising 6.5% of shipments and generating $143 million in revenue.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
